Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 4186027, 5 pages
http://dx.doi.org/10.1155/2016/4186027
Research Article

Elevated Ratio of Th17 Cell-Derived Th1 Cells (CD161+Th1 Cells) to CD161+Th17 Cells in Peripheral Blood of Early-Onset Rheumatoid Arthritis Patients

Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku, Tokyo 162-0054, Japan

Received 30 December 2015; Accepted 1 March 2016

Academic Editor: Anil K. Singh

Copyright © 2016 Shigeru Kotake et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kotake, K. Sato, K. J. Kim et al., “Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation,” Journal of Bone and Mineral Research, vol. 11, no. 1, pp. 88–95, 1996. View at Google Scholar · View at Scopus
  2. S. Kotake, N. Udagawa, N. Takahashi et al., “IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis,” The Journal of Clinical Investigation, vol. 103, no. 9, pp. 1345–1352, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. Yao, S. L. Painter, W. C. Fanslow et al., “Human IL-17: a novel cytokine derived from T cells,” Journal of Immunology, vol. 155, no. 12, pp. 5483–5486, 1995. View at Google Scholar · View at Scopus
  4. K. Sato, A. Suematsu, K. Okamoto et al., “Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction,” Journal of Experimental Medicine, vol. 203, no. 12, pp. 2673–2682, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Komatsu, K. Okamoto, S. Sawa et al., “Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis,” Nature Medicine, vol. 20, no. 1, pp. 62–68, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Raza, F. Falciani, S. J. Curnow et al., “Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin,” Arthritis Research & Therapy, vol. 7, no. 4, pp. R784–R795, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Kokkonen, I. Söderström, J. Rocklöv, G. Hallmans, K. Lejon, and S. R. Dahlqvist, “Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 62, no. 2, pp. 383–391, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Kochi, Y. Okada, A. Suzuki et al., “A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility,” Nature Genetics, vol. 42, no. 6, pp. 515–519, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Hirota, H. Yoshitomi, M. Hashimoto et al., “Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model,” Journal of Experimental Medicine, vol. 204, no. 12, pp. 2803–2812, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. H. T. Maecker, J. P. McCoy, and R. Nussenblatt, “Standardizing immunophenotyping for the Human Immunology Project,” Nature Reviews Immunology, vol. 12, no. 3, pp. 191–200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Hirahara, A. Poholek, G. Vahedi et al., “Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease,” Journal of Allergy and Clinical Immunology, vol. 131, no. 5, pp. 1276–1287, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Nakayamada, H. Takahashi, Y. Kanno, and J. J. O'Shea, “Helper T cell diversity and plasticity,” Current Opinion in Immunology, vol. 24, no. 3, pp. 297–302, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Cosmi, R. De Palma, V. Santarlasci et al., “Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor,” Journal of Experimental Medicine, vol. 205, no. 8, pp. 1903–1916, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Cosmi, R. Cimaz, L. Maggi et al., “Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis,” Arthritis and Rheumatism, vol. 63, no. 8, pp. 2504–2515, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Nistala, S. Adams, H. Cambrook et al., “Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 33, pp. 14751–14756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Annunziato, V. Santarlasci, L. Maggi, L. Cosmi, F. Liotta, and S. Romagnani, “Reasons for rarity of Th17 cells in inflammatory sites of human disorders,” Seminars in Immunology, vol. 25, no. 4, pp. 299–304, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Yamada, Y. Nakashima, K. Okazaki et al., “Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 67, no. 9, pp. 1299–1304, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. G. R. Burmester, P. Durez, G. Shestakova et al., “Association of HLA-DRB1 alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in active rheumatoid arthritis,” Rheumatology, vol. 55, no. 1, pp. 49–55, 2016. View at Publisher · View at Google Scholar
  19. J. A. A. Fischer, A. J. Hueber, S. Wilson et al., “Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody,” Arthritis and Rheumatology, vol. 67, no. 1, pp. 51–62, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Buckland, “Anti-TNF and anti-IL-17 antibodies—better together!,” Nature Reviews Rheumatology, vol. 10, no. 12, p. 699, 2014. View at Publisher · View at Google Scholar · View at Scopus